MSD's Chief AI Officer, Anton Groom, highlights AI's transformative role in drug discovery. AI models like TEDDY and KERMT are assisting scientists, identifying new drug targets and refining lead identification. This technology is accelerating the development of new medicines, with two AI-discovered molecules already in clinical trials.